価格表

在庫・価格 : 2025年04月29日 23時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-CD130, Mouse-Mono(B-P4), Azide free <Anti-gp130>
データシート※最新のデータシートでない場合があります
852.090.000 TLSダイアクローン
Diaclone SAS
200 μl 本製品は取扱中止になりました 追加

在庫・価格 : 2025年04月29日 23時55分 現在

Anti-CD130, Mouse-Mono(B-P4), Azide free <Anti-gp130>

  • 商品コード:852.090.000
  • メーカー:TLS
  • 包装:200μl
  • 本製品は取扱中止になりました
使用文献
No. 文献情報 備考 参照
1 Aoki Y et al. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus. Blood 2001 Nov;98(10):3042-9
Aoki Y et al
2001/01/01
Application: bindx gp130 PubMed
2 Friederichs K et al. Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited. Eur. J. Biochem. 2001 Dec;268(24):6401-7
Friederichs K et al
2001/01/01
Application: FC PubMed
3 Kurth I et al. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. J. Immunol. 1999 Feb;162(3):1480-7
Kurth I et al
1999/01/01
Application: FC PubMed
4 M端ller-Newen G et al. Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies. J. Biol. Chem. 2000 Feb;275(7):4579-86
M端ller-Newen G et al
2000/01/01
Application: FC PubMed
5 Pflanz S et al. Two different epitopes of the signal transducer gp130 sequentially cooperate on IL-6-induced receptor activation. J. Immunol. 2000 Dec;165(12):7042-9
Pflanz S et al
2000/01/01
Application: FC PubMed
6 Schmitz J et al. The cytoplasmic tyrosine motifs in full-length glycoprotein 130 have different roles in IL-6 signal transduction. J. Immunol. 2000 Jan;164(2):848-54
Schmitz J et al
2000/01/01
Application: FC PubMed
7 Schmitz J et al. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J. Biol. Chem. 2000 Apr;275(17):12848-56
Schmitz J et al
2000/01/01
Application: FC PubMed
8 Timmermann A et al. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor. Eur. J. Biochem. 2002 Jun;269(11):2716-26
Timmermann A et al
2002/01/01
Application: FC PubMed
9 Waetzig GH et al. N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130. J. Biol. Chem. 2010 Jan;285(3):1781-9
Waetzig GH et al
2010/01/01
Application: FC, WB PubMed
10 Classen-Linke I et al. The cytokine receptor gp130 and its soluble form are under hormonal control in human endometrium and decidua. Mol. Hum. Reprod. 2004 Jul;10(7):495-504
Classen-Linke I et al
2004/01/01
Application: IHC, WB PubMed
11 Giese B et al. Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells. J. Cell. Sci. 2005 Nov;118(Pt 21):5129-40
Giese B et al
2005/01/01
Application: Immunoflourescent staining PubMed
12 Chevalier S et al. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein. J. Biol. Chem. 1996 Jun;271(25):14764-72
Chevalier S et al
1996/01/01
Application: Inhibits IL-11 PubMed
13 Gu ZJ et al. Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M. J. Immunol. Methods 1996 Mar;190(1):21-7
Gu ZJ et al
1996/01/01
Application: inhibits IL-11 activity PubMed
14 Kurth I et al. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J. Immunol. 2000 Jan;164(1):273-82
Kurth I et al
2000/01/01
Application: IP and Immunoflourescent staining PubMed
15 Tenhumberg S et al. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130. J. Biol. Chem. 2008 Oct;283(40):27200-7
Tenhumberg S et al
2008/01/01
Application: Secondary antibody in ELISA and WB PubMed
16 Lebeau B et al. Reconstitution of two isoforms of the human interleukin-11 receptor and comparison of their functional properties. FEBS Lett. 1997 Apr;407(2):141-7
Lebeau B et al
1997/01/01
Application: Soluble detection of gp130 PubMed
17 Adam N et al. Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor. J. Virol. 2009 May;83(10):5117-26
Adam N et al
2009/01/01
Application: WB PubMed
18 Auguste P et al. Signaling of type II oncostatin M receptor. J. Biol. Chem. 1997 Jun;272(25):15760-4
Auguste P et al
1997/01/01
Application: WB PubMed
19 Buk DM et al. Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells. J. Cell. Sci. 2004 Apr;117(Pt 10):2063-75
Buk DM et al
2004/01/01
Application: WB PubMed
20 Gatsios P et al. Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock. J. Biol. Chem. 1998 Sep;273(36):22962-8
Gatsios P et al
1998/01/01
Application: WB PubMed
21 Giese B et al. Long term association of the cytokine receptor gp130 and the Janus kinase Jak1 revealed by FRAP analysis. J. Biol. Chem. 2003 Oct;278(40):39205-13
Giese B et al
2003/01/01
Application: WB PubMed
22 Montero-Julian FA et al. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family. Clin. Cancer Res. 1997 Aug;3(8):1443-51
Montero-Julian FA et al
1997/01/01
Application: WB PubMed
23 Terstegen L et al. The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130. J. Biol. Chem. 2000 Jun;275(25):18810-7
Terstegen L et al
2000/01/01
Application: WB PubMed
24 Selander KS et al. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Res. 2004 Oct;64(19):6924-33
Selander KS et al
2004/01/01
Application: WB, FC PubMed
25 Anhuf D et al. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation. J. Immunol. 2000 Sep;165(5):2535-43
Anhuf D et al
2000/01/01
Application: WB, FC PubMed
26 Wijdenes J et al. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Eur. J. Immunol. 1995 Dec;25(12):3474-81
Wijdenes J et al
1995/01/01
PubMed
  • No.: 1
  • 文献情報:
    Aoki Y et al. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus. Blood 2001 Nov;98(10):3042-9
    Aoki Y et al
    2001/01/01
  • 備考:
    Application: bindx gp130
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Friederichs K et al. Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited. Eur. J. Biochem. 2001 Dec;268(24):6401-7
    Friederichs K et al
    2001/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kurth I et al. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. J. Immunol. 1999 Feb;162(3):1480-7
    Kurth I et al
    1999/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    M端ller-Newen G et al. Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies. J. Biol. Chem. 2000 Feb;275(7):4579-86
    M端ller-Newen G et al
    2000/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Pflanz S et al. Two different epitopes of the signal transducer gp130 sequentially cooperate on IL-6-induced receptor activation. J. Immunol. 2000 Dec;165(12):7042-9
    Pflanz S et al
    2000/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Schmitz J et al. The cytoplasmic tyrosine motifs in full-length glycoprotein 130 have different roles in IL-6 signal transduction. J. Immunol. 2000 Jan;164(2):848-54
    Schmitz J et al
    2000/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Schmitz J et al. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J. Biol. Chem. 2000 Apr;275(17):12848-56
    Schmitz J et al
    2000/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Timmermann A et al. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor. Eur. J. Biochem. 2002 Jun;269(11):2716-26
    Timmermann A et al
    2002/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Waetzig GH et al. N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130. J. Biol. Chem. 2010 Jan;285(3):1781-9
    Waetzig GH et al
    2010/01/01
  • 備考:
    Application: FC, WB
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Classen-Linke I et al. The cytokine receptor gp130 and its soluble form are under hormonal control in human endometrium and decidua. Mol. Hum. Reprod. 2004 Jul;10(7):495-504
    Classen-Linke I et al
    2004/01/01
  • 備考:
    Application: IHC, WB
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Giese B et al. Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells. J. Cell. Sci. 2005 Nov;118(Pt 21):5129-40
    Giese B et al
    2005/01/01
  • 備考:
    Application: Immunoflourescent staining
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Chevalier S et al. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein. J. Biol. Chem. 1996 Jun;271(25):14764-72
    Chevalier S et al
    1996/01/01
  • 備考:
    Application: Inhibits IL-11
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Gu ZJ et al. Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M. J. Immunol. Methods 1996 Mar;190(1):21-7
    Gu ZJ et al
    1996/01/01
  • 備考:
    Application: inhibits IL-11 activity
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Kurth I et al. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J. Immunol. 2000 Jan;164(1):273-82
    Kurth I et al
    2000/01/01
  • 備考:
    Application: IP and Immunoflourescent staining
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Tenhumberg S et al. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130. J. Biol. Chem. 2008 Oct;283(40):27200-7
    Tenhumberg S et al
    2008/01/01
  • 備考:
    Application: Secondary antibody in ELISA and WB
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Lebeau B et al. Reconstitution of two isoforms of the human interleukin-11 receptor and comparison of their functional properties. FEBS Lett. 1997 Apr;407(2):141-7
    Lebeau B et al
    1997/01/01
  • 備考:
    Application: Soluble detection of gp130
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Adam N et al. Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor. J. Virol. 2009 May;83(10):5117-26
    Adam N et al
    2009/01/01
  • 備考:
    Application: WB
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Auguste P et al. Signaling of type II oncostatin M receptor. J. Biol. Chem. 1997 Jun;272(25):15760-4
    Auguste P et al
    1997/01/01
  • 備考:
    Application: WB
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Buk DM et al. Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells. J. Cell. Sci. 2004 Apr;117(Pt 10):2063-75
    Buk DM et al
    2004/01/01
  • 備考:
    Application: WB
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Gatsios P et al. Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock. J. Biol. Chem. 1998 Sep;273(36):22962-8
    Gatsios P et al
    1998/01/01
  • 備考:
    Application: WB
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Giese B et al. Long term association of the cytokine receptor gp130 and the Janus kinase Jak1 revealed by FRAP analysis. J. Biol. Chem. 2003 Oct;278(40):39205-13
    Giese B et al
    2003/01/01
  • 備考:
    Application: WB
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Montero-Julian FA et al. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family. Clin. Cancer Res. 1997 Aug;3(8):1443-51
    Montero-Julian FA et al
    1997/01/01
  • 備考:
    Application: WB
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Terstegen L et al. The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130. J. Biol. Chem. 2000 Jun;275(25):18810-7
    Terstegen L et al
    2000/01/01
  • 備考:
    Application: WB
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Selander KS et al. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Res. 2004 Oct;64(19):6924-33
    Selander KS et al
    2004/01/01
  • 備考:
    Application: WB, FC
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Anhuf D et al. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation. J. Immunol. 2000 Sep;165(5):2535-43
    Anhuf D et al
    2000/01/01
  • 備考:
    Application: WB, FC
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Wijdenes J et al. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Eur. J. Immunol. 1995 Dec;25(12):3474-81
    Wijdenes J et al
    1995/01/01
  • 備考:
  • 参照:
    PubMed